Investors didn't show much interest in one Edgewise Therapeutics way or another today. It hasn't moved too much today but is slightly down, it lost -0.68% since yesterday.
The company isn't at an immediate support or resistance level that might be predictive. But let's also consider momentum! Edgewise Therapeutics has had a nice run over the last year and provided good returns to shareholders. Over the previous year, the asset has grown 144.92 percent which isn't too bad. EWTX might find some support at the 33 level, buyers might push the price back up from here. But it's not very clear what will happen.
